UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 4
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
( ) Check this box if no longer subject to Section 16.
Form 4 or Form 5 obligations may continue. See Instructions 1(b).
1. Name and Address of Reporting Person
Lasezkay, George M.
Allergan, Inc.
2525 Dupont Drive
Irvine, CA 92612
U.S.A.
2. Issuer Name and Ticker or Trading Symbol
Allergan, Inc.
AGN
3. IRS or Social Security Number of Reporting Person (Voluntary)
4. Statement for Month/Year
April, 1997
5. If Amendment, Date of Original (Month/Year)
6. Relationship of Reporting Person(s) to Issuer (Check all applicable)
( ) Director ( ) 10% Owner ( ) Officer (give title below) (X) Other
(specify below)
Vice President, Corporate Development
7. Individual or Joint/Group Filing (Check Applicable Line)
(X) Form filed by One Reporting Person
( ) Form filed by More than One Reporting Person
<TABLE>
<CAPTION>
___________________________________________________________________________________________________________________________________
Table I -- Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned |
___________________________________________________________________________________________________________________________________|
1. Title of Security |2. |3. |4.Securities Acquired (A) |5.Amount of |6.Dir |7.Nature of Indirect |
| Transaction | or Disposed of (D) | Securities |ect | Beneficial Ownership |
| | | | Beneficially |(D)or | |
| | | | | A/| | Owned at |Indir | |
| Date |Code|V| Amount | D | Price | End of Month |ect(I)| |
___________________________________________________________________________________________________________________________________|
<S> <C> <C> <C><C> <C> <C> <C> <C> <C>
Common Stock |4/22/9|A (1|V|350 |A | | | | |
|7 |) | | | | | | | |
- -----------------------------------------------------------------------------------------------------------------------------------|
Common Stock |4/27/9|F (2|V|57 |D |$26.50 |1,048 |D | |
|7 |) | | | | | | | |
- -----------------------------------------------------------------------------------------------------------------------------------|
Common Stock | | | | | | |718.8 (3) |I |By ESOP Trust |
- -----------------------------------------------------------------------------------------------------------------------------------|
Common Stock | | | | | | |893.9 (4) |I |By 401(k) Trust |
- -----------------------------------------------------------------------------------------------------------------------------------|
___________________________________________________________________________________________________________________________________|
<CAPTION>
___________________________________________________________________________________________________________________________________
Table II -- Derivative Securitites Acquired, Disposed of, or Beneficially Owned |
___________________________________________________________________________________________________________________________________|
1.Title of Derivative |2.Con- |3. |4. |5.Number of De |6.Date Exer|7.Title and Amount |8.Price|9.Number |10.|11.Nature of|
Security |version |Transaction | rivative Secu |cisable and| of Underlying |of Deri|of Deriva |Dir|Indirect |
|or Exer | | | rities Acqui |Expiration | Securities |vative |tive |ect|Beneficial |
|cise | | | red(A) or Dis |Date(Month/| |Secu |Securities |(D)|Ownership |
|Price of| | | posed of(D) |Day/Year) | |rity |Benefi |or | |
|Deriva- | | | |Date |Expir| | |ficially |Ind| |
|tive | | | | A/|Exer-|ation| Title and Number | |Owned at |ire| |
|Secu- | | | | | D |cisa-|Date | of Shares | |End of |ct | |
|rity |Date |Code|V| Amount | |ble | | | |Month |(I)| |
___________________________________________________________________________________________________________________________________|
<S> <C> <C> <C> <C><C> <C> <C> <C> <C> <C> <C> <C> <C> <C>
Employee Stock Option |$27.00 |4/22/|A |V|22,400 |A |(5) |4/22/|Common Stock|22,400 | |33,875 |D | |
(right to buy) | |97 | | | | | |07 | | | | | | |
- -----------------------------------------------------------------------------------------------------------------------------------|
| | | | | | | | | | | | | | |
___________________________________________________________________________________________________________________________________|
</TABLE>
Explanation of Responses:
(1) Restricted stock granted under the Allergan, Inc. 1989 Incentive
Compensation Plan, in transaction exempt under Rule 16b-3(d); stock vests on
4/22/01.
(2) Shares withheld pursuant to exercise of tax withholding right under
Allergan, Inc. 1989 Incentive Compensation Plan in transaction exempt under
Rule
16b-3(e).
(3) The reporting person acquired 128.8 shares of Allergan, Inc. common stock
under the Allergan, Inc. Employee Stock Ownership Plan between
8/14/96 and
4/30/97.
(4) The reporting person acquired 103.9 shares of Allergan, Inc. common stock
under the Allergan, Inc. Savings and Investment Plan between
8/14/96 and
4/30/97.
(5) The option becomes exercisable in four equal annual installments beginning
4/22/98.
SIGNATURE OF REPORTING PERSON
/s/ George M. Lasezkay
DATE
July 22, 1997
